For buyers
Seller financing vs private credit vs sale-leaseback
Federal and state law current as of September 2026 — verify with counsel.
Key takeaways
- As of September 2026, medical marijuana is Schedule III; adult-use remains Schedule I (Federal Register 2026-08176 and pending hearing).
- 280E still hits adult-use SG&A; medical books may take ordinary deductions — apportion dual licenses.
- SBA loans are unavailable for plant-touching targets (SOP 50 10 8).
- Deals close on regulatory approval; control does not move early.
- Single-store commentary multiples of about 3x–6x EBITDA are trade ranges, not appraisals (2025–2026 commentary).
Seller financing vs private credit vs sale-leaseback is a side-by-side underwriting choice. The wrong column is how buyers overpay and sellers wait a year. This page is written for buyers and for more than one license class. It is not legal or tax advice.
On Seller financing vs private credit vs sale-leaseback, the federal overlay is a schedule split, not a national license. Federal Register 2026-08176 moved qualifying medical and FDA-approved marijuana to Schedule III on 28 April 2026. Adult-use marijuana stayed on Schedule I while a DEA hearing record sits with an administrative law judge. That is why IRC §280E still bites adult-use SG&A and why a medical slice can look different after tax.
| Topic | Working rule (verify, September 2026) |
|---|---|
| Audience | buyers |
| License lens | more than one license class |
| Contrast markets | New Jersey / Missouri / Massachusetts |
| SBA | Unavailable for plant-touching (SOP 50 10 8) |
| Hemp clock | P.L. 119-37 redefinition 12 November 2026 |
| Commentary multiple (not an appraisal) | 5x–53x normalized earnings |
People the agency will map on Seller financing vs private credit vs sale-leaseback — what breaks Seller financing vs private credit vs sale-leaseback?
True parties of interest include more than the 51% owner. Silent lenders and handshake managers show up on Seller financing vs private credit vs sale-leaseback whether the CIM mentions them or not.
Confidentiality rules for Seller financing vs private credit vs sale-leaseback — why does this change Seller financing vs private credit vs sale-leaseback?
Seller financing vs private credit vs sale-leaseback is not a Facebook post. Use a blind teaser and an NDA. Employees and landlords in New Jersey find out on a planned day.
Holdbacks that belong on Seller financing vs private credit vs sale-leaseback — what belongs on Seller financing vs private credit vs sale-leaseback?
Tax, inventory, and compliance residuals sit in escrow or a holdback. Seller financing vs private credit vs sale-leaseback that closes “clean” with open city tax is a gift to the buyer’s counsel.
What a commentary multiple is not on Seller financing vs private credit vs sale-leaseback — what should you verify for Seller financing vs private credit vs sale-leaseback?
Trade notes still cite about 3x–33x normalized earnings for a clean single store. Public MSO chatter near 4.16x EV/EBITDA for 2025 is not a value for Seller financing vs private credit vs sale-leaseback.
Hemp overlay if Seller financing vs private credit vs sale-leaseback touches SKUs — what should you verify for Seller financing vs private credit vs sale-leaseback?
P.L. 119-37 and CRS IN12620 on the 2026 hemp definition reset the definition on 12 November 2026. If Seller financing vs private credit vs sale-leaseback includes delta-8 or other intoxicating hemp, underwrite the post-rule catalog.
MSA risk around Seller financing vs private credit vs sale-leaseback — what should you verify for Seller financing vs private credit vs sale-leaseback?
A management agreement that moves control before approval is a license event. Seller financing vs private credit vs sale-leaseback does not get a clever close by calling the buyer a consultant.
Diligence order for Seller financing vs private credit vs sale-leaseback — what should you verify for Seller financing vs private credit vs sale-leaseback?
Eligibility, then local host status, then track-and-trace, then tax, then lease. The checklist stays in the working set.
Documents that actually move Seller financing vs private credit vs sale-leaseback — what breaks Seller financing vs private credit vs sale-leaseback?
License, local authorization, lease consent, tax clearance, 3 months of seed-to-sale exports, violation history, and the ownership chart. Missing one of those is not a formatting issue.
Who should not attempt Seller financing vs private credit vs sale-leaseback — what belongs on Seller financing vs private credit vs sale-leaseback?
A buyer who cannot pass background or residency. An owner inside a holding period. A non-citizen who has not spoken to immigration counsel. USCIS still treats marijuana conduct as a controlled-substance issue.
How HedgeStone treats Seller financing vs private credit vs sale-leaseback — what should you verify for Seller financing vs private credit vs sale-leaseback?
Jason Taken will say if Seller financing vs private credit vs sale-leaseback is transferable before anyone writes a CIM. He is a business broker, not an attorney and not a licensed operator. No invented listings, no invented MSO names.
Successor liability sitting under Seller financing vs private credit vs sale-leaseback — what should you verify for Seller financing vs private credit vs sale-leaseback?
Cannabis tax debt does not vanish because someone chose an asset sale. Clearance certificates and holdbacks exist for Seller financing vs private credit vs sale-leaseback. See tax holdbacks.
Banking after Seller financing vs private credit vs sale-leaseback — what breaks Seller financing vs private credit vs sale-leaseback?
FinCEN FIN-2014-G001 is still the SAR frame. A new owner who assumes the seller’s bank will keep the account is guessing. Model cash handling until the successor account is real.
When to walk away from Seller financing vs private credit vs sale-leaseback — why does this change Seller financing vs private credit vs sale-leaseback?
If the license is locked, the city will not host the buyer, the books cannot be rebuilt, or the hemp catalog dies in November 2026, the honest answer is stop. Seller financing vs private credit vs sale-leaseback is not improved by optimism.
Partner and dispute uses of Seller financing vs private credit vs sale-leaseback — why does this change Seller financing vs private credit vs sale-leaseback?
Buyouts and shareholder fights still need a method, not a slogan. Label ranges. Do not pretend a liquor-store rule prices Seller financing vs private credit vs sale-leaseback.
Cited sources that govern Seller financing vs private credit vs sale-leaseback: Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical.
What to bring to the intro call — what should you verify for Seller financing vs private credit vs sale-leaseback?
Book twenty minutes with Jason Taken at HedgeStone Business Advisors. For Seller financing vs private credit vs sale-leaseback, bring the license class, the state, the local authorization status, and whether a buyer or target is already in the room. There is no form on this site and no invented listing book. He is a business broker, not an attorney and not a licensed cannabis operator.
Related pages for Seller financing vs private credit vs sale-leaseback — what should you verify for Seller financing vs private credit vs sale-leaseback?
Read buy next if that file is open on Seller financing vs private credit vs sale-leaseback. valuation is the companion page when Seller financing vs private credit vs sale-leaseback needs that angle. Keep retail vs cultivation in the working set for Seller financing vs private credit vs sale-leaseback. Read MSO vs private next if that file is open on Seller financing vs private credit vs sale-leaseback. plant-touching vs ancillary is the companion page when Seller financing vs private credit vs sale-leaseback needs that angle. Keep buy vs apply in the working set for Seller financing vs private credit vs sale-leaseback. Read consideration types next if that file is open on Seller financing vs private credit vs sale-leaseback. sell is the companion page when Seller financing vs private credit vs sale-leaseback needs that angle.
Summary on Seller financing vs private credit vs sale-leaseback — why does this change Seller financing vs private credit vs sale-leaseback?
Seller financing vs private credit vs sale-leaseback turns on approval, after-tax cash, and the license class. Federal law current as of September 2026 is a schedule split, not a green light. Verify every rate, cap, and clock with counsel.
Which public sources belong on this file?
Cite USCIS Policy Manual, U.S. Treasury, DEA drug scheduling, DEA diversion schedules. A forum post is not a substitute.
How should you underwrite Seller financing vs private credit vs sale-leaseback?
Seller financing vs private credit vs sale-leaseback has to verify as a license-and-tax file. In New York, scarcity can dominate. In Virginia, paper value can be near zero. Cited sources that govern Seller financing vs private credit vs sale-leaseback: SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026. Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E.
| Check | New York | Virginia |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
Frequently asked questions
Who counts as a true party of interest?
More than the 51% owner. Silent lenders and handshake managers show up whether the CIM mentions them or not. Map them before you price this file.
Does tax debt vanish in an asset sale?
No. Cannabis tax claims can follow the buyer or the assets. Clearance certificates and holdbacks exist for this file.
Does a public listing raise the price?
Usually it raises leakage risk. Employees, landlords, and competitors learn first. Run this file as a confidential process.
What should you bring to the intro call?
License class, state, local authorization status, and whether a buyer or target is already in the room. That is enough to qualify this file.
How should dual licenses be taxed?
Apportion. The April 2026 order is not a blended gift. Dual shops that dump all SG&A into the medical column will lose that fight on this file.
What is the first buyer screen?
Eligibility: residency, ownership caps, background, and every true party of interest. A cheap asset you cannot own is not cheap. Start there on this file.
Sources
- IRC §280E — https://www.law.cornell.edu/uscode/text/26/280E
- Viridian Capital public commentary — Tier 1 U.S. MSO EV/EBITDA ~4.16x (2025 consensus)
- Federal Register 2026-08176 (28 April 2026) — medical / FDA-approved marijuana to Schedule III — https://www.federalregister.gov/d/2026-08176
- FinCEN FIN-2014-G001 — BSA expectations for marijuana-related businesses — https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
- SBA SOP 50 10 8 (effective 1 June 2025) — marijuana ineligibility — https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs
- USCIS Policy Manual — https://www.uscis.gov/policy-manual
- U.S. Treasury — https://home.treasury.gov/
- DEA drug scheduling — https://www.dea.gov/drug-information/drug-scheduling
- Congress.gov S.4942 — SAFE Banking Act of 2026 (introduced, not enacted) — https://www.congress.gov/bill/119th-congress/senate-bill/4942
- Congress.gov H.R.9471 — companion SAFE Banking bill — https://www.congress.gov/bill/119th-congress/house-bill/9471
- CRS IF13136 / IN12620 — hemp definition change effective 12 November 2026 (P.L. 119-37) — https://www.congress.gov/crs-product/IN12620